FBXL13
Dynein regulatory complex subunit 6
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
histone modification site profile | 0.82 | ||
transcription factor binding site profile | 0.8 | ||
transcription factor | 0.67 | ||
tissue sample | 0.57 | ||
tissue | 0.5 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Adaptive Immune System | ||||
Reactome | Antigen processing: Ubiquitination & Proteasome degradation | ||||
Reactome | Class I MHC mediated antigen processing & presentation | ||||
Reactome | Immune System | ||||
Reactome | Metabolism of proteins | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Adaptive Immune System | ||||
Antigen processing: Ubiquitination & Proteasome degradation | ||||
Class I MHC mediated antigen processing & presentation | ||||
Immune System | ||||
Metabolism of proteins | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Experiment (EXP) | Reactome | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
chronotype measurement | 2 | 7 | 4 | 1 | 96.6 | ||||
2 | 2 | 1 | 1.1 | 57.8 | |||||
circadian rhythm | 1 | 1 | 0 | 1.1 | 28.1 | ||||
1 | 1 | 0 | 10.7 | 24.5 | |||||
mental or behavioural disorder | 1 | 1 | 0 | 10.7 | 24.5 | ||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
chronotype measurement | 4 | 1 | 96.6 | ||||
1 | 1.1 | 57.8 | |||||
circadian rhythm | 0 | 1.1 | 28.1 | ||||
0 | 10.7 | 24.5 | |||||
mental or behavioural disorder | 0 | 10.7 | 24.5 | ||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | F-box and leucine rich repeat protein 13 | VGNC:4354 | 463628 | |||||
Macaque | F-box and leucine rich repeat protein 13 | 695089 | ||||||
Mouse | MGI:2443416 | 320118 | ||||||
Dog | F-box and leucine rich repeat protein 13 | VGNC:51872 | 609997 | |||||
Horse | F-box and leucine rich repeat protein 13 | VGNC:52383 | 100058236 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | F-box and leucine rich repeat protein 13 | |||||
Macaque | F-box and leucine rich repeat protein 13 | |||||
Mouse | ||||||
Dog | F-box and leucine rich repeat protein 13 | |||||
Horse | F-box and leucine rich repeat protein 13 | |||||
PMID | Year | Title |
---|